Castle Creek Biosciences Expands its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders through Research Collaboration with Mayo ClinicSeptember 29th, 2021|Cell and Gene Therapy, Innovation, Regional News Roundup|0 Comments Castle Creek Biosciences, Inc. announces research collaboration with Mayo Clinic.Article from PR NewswireShare This Story, Choose Your PlatformFacebookTwitterLinkedInPinterestEmail Related Posts Stories From Our Region – July 2022 Stories From Our Region – June 2022 Greater Philadelphia Region Seeks ARPA-H Home Letter to HHS Secretary Points Out Region’s Significant Assets Penn Announces Strategic Partnership with Longfellow Real Estate to Develop State-of-the-Art Life Sciences Facility in Philadelphia Stories From Our Region – May 2022 Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Current ye@r * Leave this field empty
Leave A Comment